GRPR and neoplasm: Based on the positive outcome of this study, in which the tracer was well tolerated, and variable tumor-specific uptake was observed, the targeting properties of [68Ga]Ga-NeoBOMB1 in patients with other malignancies known to overexpress GRPR were investigated (NCT03724253, ref. [26]).